Open AccessRasGRP1 is a causal factor in the development of l -DOPA–induced dyskinesia in Parkinson’s disease
Author(s) -
Mehdi Eshraghi,
Uri Nimrod Ramírez-Jarquín,
Neelam Shahani,
Tommaso Nuzzo,
Arianna De Rosa,
Supriya Swarnkar,
Nicole Galli,
Oscar Rivera,
George Tsaprailis,
Catherina Scharager-Tapia,
Gogce Crynen,
Qin Li,
Marie-Laure Thiolat,
Erwan Bézard,
Alessandro Usiello,
Srinivasa Subramaniam
Publication year - 2020
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.aaz7001
Subject(s) - dyskinesia , parkinson's disease , disease , neuroscience , paroxysmal dyskinesia , medicine , psychology , bioinformatics , biology
A novel molecular target that signals abnormal involuntary movement in Parkinson’s disease treatment is discovered.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom